- Home
- IGC vs GRYP Comparison
IGC vs GRYP Comparison
Compare IGC & GRYP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IGC
- GRYP
- Stock Information
- Founded
- IGC 2005
- GRYP 2010
- Country
- IGC United States
- GRYP United States
- Employees
- IGC N/A
- GRYP N/A
- Industry
- IGC Biotechnology: Pharmaceutical Preparations
- GRYP
- Sector
- IGC Health Care
- GRYP
- Exchange
- IGC Nasdaq
- GRYP Nasdaq
- Market Cap
- IGC 29.4M
- GRYP 25.7M
- IPO Year
- IGC N/A
- GRYP N/A
- Fundamental
- Price
- IGC $0.31
- GRYP $0.21
- Analyst Decision
- IGC Strong Buy
- GRYP Hold
- Analyst Count
- IGC 2
- GRYP 1
- Target Price
- IGC $3.88
- GRYP N/A
- AVG Volume (30 Days)
- IGC 392.1K
- GRYP 824.2K
- Earning Date
- IGC 02-18-2025
- GRYP 04-01-2025
- Dividend Yield
- IGC N/A
- GRYP N/A
- EPS Growth
- IGC N/A
- GRYP N/A
- EPS
- IGC N/A
- GRYP N/A
- Revenue
- IGC $1,236,000.00
- GRYP $22,783,000.00
- Revenue This Year
- IGC N/A
- GRYP N/A
- Revenue Next Year
- IGC $18.34
- GRYP N/A
- P/E Ratio
- IGC N/A
- GRYP N/A
- Revenue Growth
- IGC 1.64
- GRYP 14.06
- 52 Week Low
- IGC $0.26
- GRYP $0.18
- 52 Week High
- IGC $0.91
- GRYP $1.90
- Technical
- Relative Strength Index (RSI)
- IGC 52.84
- GRYP 31.38
- Support Level
- IGC $0.26
- GRYP $0.23
- Resistance Level
- IGC $0.34
- GRYP $0.32
- Average True Range (ATR)
- IGC 0.02
- GRYP 0.03
- MACD
- IGC 0.01
- GRYP -0.01
- Stochastic Oscillator
- IGC 65.88
- GRYP 17.33
About IGC IGC Pharma Inc.
IGC Pharma Inc develops advanced cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease, IGC-AD1 and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles. IGC-AD1 is a low-dose tetrahydrocannabinol-based formulation that is in a 146-person Phase 2 clinical trial for agitation in dementia due to Alzheimer's. IGC also markets a wellness brand, Holief, that targets women experiencing premenstrual syndrome and menstrual cramps.
About GRYP Gryphon Digital Mining Inc Common Stock
Gryphon Digital Mining Inc is a Bitcoin mining company. Gryphon's mission is to create the world's leading net carbon-neutral Bitcoin miner. The company will operate a digital asset, mining operation using specialized computers equipped with application-specific integrated circuit (ASIC) chips to solve complex cryptographic algorithms in support of the Bitcoin blockchain in exchange for cryptocurrency rewards (primarily Bitcoin).